Sinecch
Loading...Sinecch Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Warnings: If you are pregnant or nursing, consult your physician before taking SinEcch. For multiple procedures during a 4 week interval, take only 1 SinEcch regimen with the final procedure.
Do not drink or eat anything for 15 minutes before and after taking SinEcch.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Surgery or Major Trauma
History
There is currently no drug history available for this drug.
Other Information
There are no additional details available for this product.
Sources
Sinecch Manufacturers
-
Hahnemann Laboratories, Inc. Dba Alpine Pharmaceuticals
![Sinecch (Arnica Montana) Capsule [Hahnemann Laboratories, Inc. Dba Alpine Pharmaceuticals]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Sinecch | Teva Pharmaceuticals Usa Inc
2.1 Acute Treatment of Migraine AttacksThe recommended dose of almotriptan malate tablets in adults and adolescents age 12 to 17 years is 6.25 mg to 12.5 mg, with the 12.5 mg dose tending to be a more effective dose in adults. As individuals may vary in their response to different doses of almotriptan malate tablets, the choice of dose should be made on an individual basis.
If the headache is relieved after the initial almotriptan malate tablets dose but returns, the dose may be repeated after 2 hours. The effectiveness of a second dose has not been established in placebo-controlled trials. The maximum daily dose should not exceed 25 mg. The safety of treating an average of more than four migraines in a 30-day period has not been established.
2.2 Hepatic ImpairmentThe recommended starting dose of almotriptan malate tablets in patients with hepatic impairment is 6.25 mg. The maximum daily dose should not exceed 12.5 mg over a 24-hour period [see Warnings and Precautions (5.9) and Clinical Pharmacology (12.3)].
2.3 Renal ImpairmentThe recommended starting dose of almotriptan malate tablets in patients with severe renal impairment is 6.25 mg. The maximum daily dose should not exceed 12.5 mg over a 24-hour period [see Warnings and Precautions (5.9) and Clinical Pharmacology (12.3)].
Login To Your Free Account